Compugen (CGEN) EBITDA Margin Growth (3y) (2012 - 2025)

Compugen (CGEN) EBITDA Margin Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 13,029.00
Dec 31, 2023 50,830.00
Sep 30, 2018 297,650.00
Dec 31, 2016 -1.63 Mn
Sep 30, 2016 -1.11 Mn
Jun 30, 2016 2.00 Mn
Mar 31, 2016 -709,180.00
Dec 31, 2015 285,767.00
Sep 30, 2015 33,634.00
Dec 31, 2013 98,754.00
Jun 30, 2013 -2.13 Mn
Mar 31, 2013 -27,251.00
Dec 31, 2012 493,758.00
Sep 30, 2012 -546,389.00